The group builds its moat by investing heavily in a diverse pharmaceutical pipeline. The segment includes psoriasis drugs like Stelara and Tremfya, myeloma treatment Darzalex, and prostate cancer …
More Should You Buy Johnson & Johnson Stock in October? Videos